Healthcare data analytics company, MediMergent, and the FDA’s Center for Drug Evaluation and Research reportedly gathered stakeholders from biopharma companies, pharmacies, health plans and regulatory agencies to propose strategies regarding medication non-adherence.
Approximately half of all Americans with chronic diseases who need lifelong medications do not stick to their prescribed regimen six months after they begin therapy, according to MediMergent. It’s a problem that results in up to $300 billion in added healthcare costs, the company said.
Get the full story at our sister site, Drug Delivery Business News.
The post MediMergent and FDA team up to tackle medication adherence appeared first on MassDevice.
from MassDevice https://ift.tt/2JQFLkn
Cap comentari:
Publica un comentari a l'entrada